We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+17.1%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$72.5B
AUM Growth
+$8.64B
(+14%)
Cap. Flow
-$411M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
21.89%
Holding
3,099
New
114
Increased
2,324
Reduced
599
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$278M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$23.1M |
| 3 |
Morgan Stanley
MS
|
+$22.8M |
| 4 |
AIRC
Apartment Income REIT Corp.
AIRC
|
+$18.5M |
| 5 |
Peloton Interactive
PTON
|
+$17.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$108M |
| 2 |
Microsoft
MSFT
|
+$73.2M |
| 3 |
Amazon
AMZN
|
+$49.5M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$27.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.78% |
| 2 | Financials | 13.46% |
| 3 | Healthcare | 13.26% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Communication Services | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Atea Pharmaceuticals
AVIR
$420M
| $523K | ﹤0.01% |
+12,516
| New | +$403K |
|
|
AUD
2427
DELISTED
Audacy, Inc.
AUD
| $523K | ﹤0.01% |
211,628
+24,690
| +13% | +$50.4K |
|
|
BELFB
2428
Bel Fuse Inc Class B
BELFB
$4.21B
| $521K | ﹤0.01% |
34,646
+4,592
| +15% | +$61.8K |
|
2429
Anterix
ATEX
$1.94B
| $519K | ﹤0.01% |
13,798
+800
| +6% | +$26.4K |
|
2430
Artesian Resources
ARTNA
$358M
| $518K | ﹤0.01% |
13,971
+1,626
| +13% | +$60.4K |
|
2431
Oportun Financial
OPRT
$372M
| $518K | ﹤0.01% |
26,738
+4,154
| +18% | +$67.9K |
|
2432
Oppenheimer Holdings
OPY
$1.2B
| $516K | ﹤0.01% |
16,428
+1,732
| +12% | +$48.8K |
|
2433
UroGen Pharma
URGN
$2.29B
| $516K | ﹤0.01% |
28,648
+3,131
| +12% | +$65.6K |
|
|
CLVS
2434
DELISTED
Clovis Oncology, Inc.
CLVS
| $516K | ﹤0.01% |
107,436
+8,955
| +9% | +$45.3K |
|
|
SYRS
2435
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $515K | ﹤0.01% |
4,748
+259
| +6% | +$23.6K |
|
2436
Allegro MicroSystems
ALGM
$8.16B
| $512K | ﹤0.01% |
+19,204
| New | +$464K |
|
2437
UFP Technologies
UFPT
$2.43B
| $512K | ﹤0.01% |
10,980
+1,369
| +14% | +$59.7K |
|
2438
West Bancorporation
WTBA
$485M
| $506K | ﹤0.01% |
26,194
+3,040
| +13% | +$56.6K |
|
|
AWH
2439
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $504K | ﹤0.01% |
5,010
+986
| +25% | +$65.8K |
|
2440
Hingham Institution for Saving
HIFS
$663M
| $502K | ﹤0.01% |
2,324
+288
| +14% | +$61.3K |
|
2441
Lifecore Biomedical
LFCR
$190M
| $499K | ﹤0.01% |
45,989
+5,437
| +13% | +$56.2K |
|
2442
Lindblad Expeditions
LIND
$2.22B
| $499K | ﹤0.01% |
29,166
+3,180
| +12% | +$36.4K |
|
2443
Amerant Bancorp
AMTB
$1.13B
| $497K | ﹤0.01% |
32,695
+4,768
| +17% | +$61.7K |
|
2444
National CineMedia
NCMI
$378M
| $497K | ﹤0.01% |
13,349
+2,633
| +25% | +$80.1K |
|
|
RNAM
2445
DELISTED
Avidity Biosciences
RNAM
| $493K | ﹤0.01% |
19,312
+1,796
| +10% | +$52.4K |
|
|
BDSI
2446
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $493K | ﹤0.01% |
117,387
+6,490
| +6% | +$25K |
|
2447
Old Second Bancorp
OSBC
$1.29B
| $491K | ﹤0.01% |
48,578
+5,981
| +14% | +$56.8K |
|
2448
Uranium Energy
UEC
$5.57B
| $491K | ﹤0.01% |
279,259
+32,952
| +13% | +$38.9K |
|
2449
Accel Entertainment
ACEL
$987M
| $490K | ﹤0.01% |
48,505
+4,900
| +11% | +$51.3K |
|
2450
Merchants Bancorp
MBIN
$2.49B
| $490K | ﹤0.01% |
26,585
+2,742
| +12% | +$45.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2020 Portfolio in Review
As of Q4 2020, RhumbLine Advisers held 3,099 positions worth $72.5B, up 14% from $63.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers's Q4 2020 filing shows 114 new, 2,324 increased, 599 reduced and 47 closed positions. Its largest new stake was Apartment Income REIT Corp.: 482,605 shares worth $18.5M. The largest sale was Apple, an estimated $108M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2020 buy was Apartment Income REIT Corp.: 482,605 shares worth $18.5M.
- RhumbLine Advisers added most to Tesla in Q4 2020, an estimated $278M increase.
- RhumbLine Advisers's biggest Q4 2020 reduction was Apple, cutting an estimated $108M.
- RhumbLine Advisers fully exited Immunomedics Inc in Q4 2020, selling an estimated $20.4M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $72.5B portfolio in Q4 2020.
- RhumbLine Advisers opened 114 new positions and closed 47 in Q4 2020.
- RhumbLine Advisers's portfolio value rose 14% quarter-over-quarter to $72.5B.
Based on RhumbLine Advisers's 13F filing for Q4 2020, filed 10 Feb 2021.